Clinical Features and Prognostic Implications of Severe Corticosteroid-Treated Cryptogenic Chronic Active Hepatitis
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 65 (1) , 23-30
- https://doi.org/10.1016/s0025-6196(12)62106-5
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- HLA typing and autoantibodies in hepatitis B surface antigen-negative chronic active hepatitisTissue Antigens, 2008
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Subdivisions of idiopathic autoimmune chronic active hepatitisHepatology, 1987
- Frequency and significance of antibody to double-stranded DNA in chronic active hepatitisHepatology, 1986
- Complete Resolution of Inflammatory Activity Following Corticosteroid Treatment of HBsAg-Negative Chronic Active Hepatitis†Hepatology, 1984
- Strategies in the Management of Chronic Active HepatitisDigestive Diseases, 1984
- Natural History, Clinical Features, and Treatment of Autoimmune HepatitisSeminars in Liver Disease, 1984
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- A CLASSIFICATION OF CHRONIC HEPATITISThe Lancet, 1968